Caris Life Sciences' stock is being examined in the context of its gross margin, which has reportedly increased significantly. The company's gross margin growth is being compared to that of other companies, such as Formula One Group and Zscaler, which have also seen notable changes in their gross margins. The implications of these changes for the stocks of these companies, including Caris Life Sciences, are being considered.